Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1175175 (
SARS
)
19,188
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Severe acute respiratory syndrome
(
SARS
) is a new disease which has spread rapidly and widely. We wished to know whether evaluation of in vitro cytokine production could contribute to improved understanding of disease pathogenesis and to better patient management. Numbers of unstimulated and mitogen-stimulated cytokine-secreting peripheral blood mononuclear cells were measured repeatedly during and after hospitalization in 13 patients with
SARS
using enzyme-linked immunospot technology. Numbers of interferon-gamma, interleukin (IL)-2,
IL-4
, IL-10 and IL-12 secreting cells induced by T cell activators were below normal in many or most patients before and during treatment with corticosteroids and ribavirin but returned essentially to normal after completion of treatment. Staphylococcus aureus Cowan 1 (SAC)-stimulated IL-10 secreting cells were increased in early
SARS
but fell during treatment. SAC-induced IL-12 secreting cells were deficient before, during and long after treatment. Numbers of cells induced to produce IL-6 and tumour necrosis factor-alpha by T cell or monocyte activators were higher than normal in many early
SARS
patients and were still increased in some during and after treatment. We conclude that prolonged dysregulated cytokine production occurs in
SARS
and that future studies should be directed at improving anti-inflammatory and antiviral therapies in order to limit cytokine impairment.
...
PMID:Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids. 1503 May 7
Severe acute respiratory syndrome
(
SARS
) is a recently emerged infectious disease caused by a novel coronavirus, but its immunopathological mechanisms have not yet been fully elucidated. We investigated changes in plasma T helper (Th) cell cytokines, inflammatory cytokines and chemokines in 20 patients diagnosed with
SARS
. Cytokine profile of
SARS
patients showed marked elevation of Th1 cytokine interferon (IFN)-gamma, inflammatory cytokines interleukin (IL)-1, IL-6 and IL-12 for at least 2 weeks after disease onset, but there was no significant elevation of inflammatory cytokine tumour necrosis factor (TNF)-alpha, anti-inflammatory cytokine IL-10, Th1 cytokine IL-2 and Th2 cytokine
IL-4
. The chemokine profile demonstrated significant elevation of neutrophil chemokine IL-8, monocyte chemoattractant protein-1 (MCP-1), and Th1 chemokine IFN-gamma-inducible protein-10 (IP-10). Corticosteroid reduced significantly IL-8, MCP-1 and IP-10 concentrations from 5 to 8 days after treatment (all P < 0.001). Together, the elevation of Th1 cytokine IFN-gamma, inflammatory cytokines IL-1, IL-6 and IL-12 and chemokines IL-8, MCP-1 and IP-10 confirmed the activation of Th1 cell-mediated immunity and hyperinnate inflammatory response in
SARS
through the accumulation of monocytes/macrophages and neutrophils.
...
PMID:Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. 1503 May 7
Severe acute respiratory syndrome
(
SARS
) is an acute infectious disease of the respiratory system. Although a novel coronavirus has been identified as the causative agent of
SARS
, the pathogenic mechanisms of
SARS
are not understood. In this study, sera were collected from healthy donors, patients with
SARS
, patients with severe
SARS
, and patients with
SARS
in convalescence. The serum concentrations of interleukin-1 (IL-1),
IL-4
, IL-6, IL-8, IL-10, tumor growth factor beta (TGF-beta), tumor necrosis factor alpha (TNF-alpha), and gamma interferon (IFN-gamma) were measured by enzyme-linked immunosorbent assays (ELISA). The concentrations of IL-1 and TNF-alpha were not significantly different in different groups. The IL-6 concentration was increased in
SARS
patients and was significantly elevated in severe
SARS
patients, but the IL-6 concentrations were similar in convalescent patients and control subjects, suggesting that there was a positive relationship between the serum IL-6 concentration and
SARS
severity. The concentrations of IL-8 and TGF-beta were decreased in
SARS
patients and significantly reduced in severe
SARS
patients, but they were comparable in convalescent
SARS
patients and control subjects, suggesting that there was a negative relationship between the IL-8 and TGF-beta concentrations and
SARS
severity. The concentrations of IFN-gamma,
IL-4
, and IL-10 showed significant changes only in convalescent
SARS
patients. The IFN-gamma and
IL-4
levels were decreased, while the levels of IL-10 were increased, and the differences between convalescent
SARS
patients and other patient groups were statistically significant. These results suggest that there are different immunoregulatory events during and after
SARS
and may contribute to our understanding of the pathogenesis of this syndrome.
...
PMID:Analysis of serum cytokines in patients with severe acute respiratory syndrome. 1527 97
The recent emergence of
severe acute respiratory syndrome
(
SARS
) was caused by a novel coronavirus,
SARS
-CoV. It spread rapidly to many countries and developing a
SARS
vaccine is now urgently required. In order to study the immunogenicity of UV-inactivated purified
SARS
-CoV virion as a vaccine candidate, we subcutaneously immunized mice with UV-inactivated
SARS
-CoV with or without an adjuvant. We chose aluminum hydroxide gel (alum) as an adjuvant, because of its long safety history for human use. We observed that the UV-inactivated
SARS
-CoV virion elicited a high level of humoral immunity, resulting in the generation of long-term antibody secreting and memory B cells. With the addition of alum to the vaccine formula, serum IgG production was augmented and reached a level similar to that found in hyper-immunized mice, though it was still insufficient to elicit serum IgA antibodies. Notably, the
SARS
-CoV virion itself was able to induce long-term antibody production even without an adjuvant. Anti-
SARS
-CoV antibodies elicited in mice recognized both the spike and nucleocapsid proteins of the virus and were able to neutralize the virus. Furthermore, the UV-inactivated virion induced regional lymph node T-cell proliferation and significant levels of cytokine production (IL-2,
IL-4
, IL-5, IFN-gamma and TNF-alpha) upon restimulation with inactivated
SARS
-CoV virion in vitro. Thus, a whole killed virion could serve as a candidate antigen for a
SARS
vaccine to elicit both humoral and cellular immunity.
...
PMID:A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. 1531 40
Fourteen cytokines or chemokines were analyzed on 88 RT-PCR-confirmed
severe acute respiratory syndrome
(
SARS
) patients. IFN-gamma, IL-18, TGF-beta, IL-6, IP-10, MCP-1, MIG, and IL-8, but not of TNF-alpha, IL-2,
IL-4
, IL-10, IL-13, or TNFRI, were highly elevated in the acute phase sera of Taiwan
SARS
patients. IFN-gamma was significantly higher in the Ab(+) group than in the Ab(-) group. IFN-gamma, IL-18, MCP-1, MIG, and IP-10 were already elevated at early days post fever onset. Furthermore, levels of IL-18, IP-10, MIG, and MCP-1 were significantly higher in the death group than in the survival group. For the survival group, IFN-gamma and MCP-1 were inversely associated with circulating lymphocytes count and monocytes count, but positively associated with circulating neutrophils count. It is concluded that an interferon-gamma-related cytokine storm was induced post
SARS
coronavirus infection, and this cytokine storm might be involved in the immunopathological damage in
SARS
patients.
...
PMID:An interferon-gamma-related cytokine storm in SARS patients. 1560 37
Severe acute respiratory syndrome
(
SARS
), caused by a novel coronavirus, emerged in early 2003 as a major international health crisis. We report on serum cytokine levels, viral load and clinical parameters over the course of the disease in a cohort of nine adult
SARS
patients treated with steroids and interferon alfacon-1 at North York General Hospital in Toronto, Ontario. Considerable variation among
SARS
patients with respect to circulating viral load and patterns of
SARS
-CoV-evoked cytokine responses was recorded. No single cytokine profile was observed in all patients, yet serum concentrations of interferon (IFN)-gamma, interleukin (IL)-10, CXCL10, CCL5 and CXCL8 were found to be elevated above normal levels during the course of the disease in all patients. Expression levels for IL-10, IFN-gamma and CXCL10 consistently peaked within 4 days of peak viral load. IL-12p70,
IL-4
and tumour necrosis factor-alpha concentrations were consistently highest within 5 days of peak viral load. These results suggest that elevated levels of inflammatory cytokines are sensitive correlates of disease severity, including lung abnormalities and viral load in serum, and may provide a tool for monitoring disease progression in affected individuals.
...
PMID:Dynamic changes in clinical features and cytokine/chemokine responses in SARS patients treated with interferon alfacon-1 plus corticosteroids. 1586 21
Correspondence between the T-cell epitope responses of vaccine immunogens and those of pathogen antigens is critical to vaccine efficacy. In the present study, we analyzed the spectrum of immune responses of mice to three different forms of the
SARS
coronavirus nucleocapsid (N): (1) exogenous recombinant protein (N-GST) with Freund's adjuvant; (2) DNA encoding unmodified N as an endogenous cytoplasmic protein (pN); and (3) DNA encoding N as a LAMP-1 chimera targeted to the lysosomal MHC II compartment (p-LAMP-N). Lysosomal trafficking of the LAMP/N chimera in transfected cells was documented by both confocal and immunoelectron microscopy. The responses of the immunized mice differed markedly. The strongest T-cell IFN-gamma and CTL responses were to the LAMP-N chimera followed by the pN immunogen. In contrast, N-GST elicited strong T cell
IL-4
but minimal IFN-gamma responses and a much greater antibody response. Despite these differences, however, the immunodominant T-cell ELISpot responses to each of the three immunogens were elicited by the same N peptides, with the greatest responses being generated by a cluster of five overlapping peptides, N76-114, each of which contained nonameric H2d binding domains with high binding scores for both class I and, except for N76-93, class II alleles. These results demonstrate that processing and presentation of N, whether exogenously or endogenously derived, resulted in common immunodominant epitopes, supporting the usefulness of modified antigen delivery and trafficking forms and, in particular, LAMP chimeras as vaccine candidates. Nevertheless, the profiles of T-cell responses were distinctly different. The pronounced Th-2 and humoral response to N protein plus adjuvant are in contrast to the balanced IFN-gamma and
IL-4
responses and strong memory CTL responses to the LAMP-N chimera.
...
PMID:SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens. 1638 39
The immune effect of two recombinant protein fragments of spike protein in
severe acute respiratory syndrome
coronavirus (
SARS
CoV) was investigated in Balb/c mice. Two partial spike gene fragments S1 (322 1464 bp) and S2 (2170 2814 bp) of
SARS
coronavirus were amplified by RT-PCR, and cloned into pET-23a prokaryotic expression vector, then transformed into competent Escherichia E. coli BL21 (DE3)(pLysS) respectively. Recombinant proteins were expressed and purified by Ni2+ immobilized metal ion affinity chromatography. The purified proteins mixed with complete Freund adjuvant were injected into Balb/c mice three times at a two-week interval. High titer antibody was detected in the serum of immunized Balb/c mice, and mice immunized with S1 protein produced high titer IgG1, IgG2a, IgG2b and IgG3, while those immunized with S2 protein produced high titer IgG1, IgG2a, but lower titer IgG2b and IgG3. Serum IFN-concentration was increased significantly but the concentrations of Il-2,
IL-4
and IL-10 had no significant change. And a marked increase was observed in the number of spleen CD8+ T cells. The results showed that recombinant proteins of
SARS
coronavirus spike protein induced hormonal and cellular immune response in Balb/c mice.
...
PMID:The immunity induced by recombinant spike proteins of SARS coronavirus in Balb/c mice. 1764 27
Continuous efforts have been made to develop a prophylactic vaccine against
severe acute respiratory syndrome
coronavirus (SARS-CoV). In this study, two recombinant baculoviruses, vAc-N and vAc-S, were constructed, which contained the mammalian-cell activate promoter element, human elongation factor 1alpha-subunit (EF-1alpha), the human cytomegalovirus (CMV) immediate-early promoter, and the nucleocapsid (N) or spike (S) gene of bat
SARS
-like CoV (SL-CoV) under the control of the CMV promoter. Mice were subcutaneously and intraperitoneally injected with recombinant baculovirus, and both humoral and cellular immune responses were induced in the vaccinated groups. The secretion level of IFN-gamma was much higher than that of
IL-4
in vAc-N or vAc-S immunized groups, suggesting a strong Th1 bias towards cellular immune responses. Additionally, a marked increase of CD4 T cell immune responses and high levels of anti-
SARS
-CoV humoral responses were also detected in the vAc-N or vAc-S immunized groups. In contrast, there were significantly weaker cellular immune responses, as well as less antibody production than in the control groups. Our data demonstrates that the recombinant baculovirus can serve as an effective vaccine strategy. In addition, because effective
SARS
vaccines should act to not only prevent the reemergence of
SARS
-CoV, but also to provide cross-protection against SL-CoV, findings in this study may have implications for developing such cross-protective vaccines.
...
PMID:Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. 1790 35
1. A genetic risk-association study involving more than 1200 subjects showed individuals homozygous for L-SIGN tandem repeats are less susceptible to
SARS
infection. 2. This was supported by in vitro binding studies that demonstrated homozygous L-SIGN, compared to heterozygous, had higher binding capacity for
SARS
coronavirus (SARS-CoV), with higher proteasome-dependent viral degradation. In contrast, homozygous L-SIGN demonstrated lower binding capacity for HIV1-gp120.3. Genetic-association studies for single nucleotide polymorphisms of the inflammatory response genes, namely TNF-alpha, INF-alpha, INF-beta, INF-gamma, IL1-alpha, IL1-beta,
IL-4
, IL-6 and iNOS, failed to show a significant association with
SARS
clinical outcomes or susceptibility.
...
PMID:Role of polymorphisms of the inflammatory response genes and DC-SIGNR in genetic susceptibility to SARS and other infections. 1870 72
1
2
3
4
Next >>